Luo Wenjing,Pu Chuanqiang,Shi Qiang.Factors influencing prognosis of 90 polymyositis and dermatomyositis patients[J].J Amry Med Univ (J Third Mil Med Univ),2010,32(08):842-845.
Luo Wenjing,Pu Chuanqiang,Shi Qiang.Factors influencing prognosis of 90 polymyositis and dermatomyositis patients[J].J Amry Med Univ (J Third Mil Med Univ),2010,32(08):842-845.DOI:
Factors influencing prognosis of 90 polymyositis and dermatomyositis patients
Objective To study the prognosis of polymyositis (PM) and dermatomyositis (DM) patients and its influence factors. Methods Sixty DM and 30 PM patients diagnosed according to the diagnostic criteria of Bohan and Peter in our hospital during 2000-2008 were used as study subjects. The patients were followed up till their death or to August 2009. Gender
age of disease onset
disease course
serum creatine kinase
interstitial lung disease
heart involvement
connective tissue disease (CTD)
malignancies
and treatment with corticosteroids
immunoglobulin and immunosuppressive agents were assessed as predictive factors for the prognosis of patients. Characteristics of muscular biopsy from 20 cases were analyzed. Results The median age of the 90 patients (29 males and 61 females) was 51 years (range 6-74 years). The male and female ratio was 1∶2. The most commonly involved muscles were the proximal muscles of limbs (83.3%)
followed by neck muscles (25.6%)
laryngea pharyngeal muscles (12.2%) and masticatory muscles (2.2%). Among the 42 patients(46.7%)with lung disease
interstitial lung disease and hear involvement were found in 29 (32.2%)and 13(14.4%)patients
respectively. Of the 13 patients complicated by connective tissue disease
DM and PM accompanying connective tissue disease were diagnosed in 9 and 4
respectively
and DM and PM accompanying malignancies were observed in 2 patients. Muscular or skin biopsy was performed for 23 patients
which showed typical inflammatory infiltration in 13
dermatomyositis in 3
and no significant lesion in 2 patients
respectively. Of the 18 patients who died during the follow-up
5 (16.67%) and 13 (21.67%) died of PM and DM
respectively. Seventy-two patients survived. Their 1-
5-
and 9- year survival rate was 90%
84.4%
and 80%
respectively. The complete and partial remission rate was 22.2% and 36.7%
respectively
with a relapse rate of 20%. Advanced age of disease onset (P=0.003 8)
interstitial lung disease (P=0.011 3) and malignancies (P=0.004 9) were main causes of death. Malignancy(RR=6.34,P=0.001 2)was the factor for poor prognosis and long-term treatment with hormones and immunosuppressive agents is the protective factor for PM and DM. Conclusion Complete and partial remission can be achieved in 58.9% patients with DM and PM. Advanced age of disease onset
interstitial lung disease and malignancy are the factors for poor prognosis of such patients. Long-term treatment with corticosteroids and immunosuppressive agents are the protective factors.
A novel estrogen receptor expression stratification (low/moderate/high) based on Chinese population provides more accurate prognosis prediction for HR+/HER2- early breast cancer patients
Immunosuppressive microenvironment of TGIF1-overexpressing gastric cancers and its clinical significance
Impact of molecular heterogeneity of NPM1 mutations on prognosis of acute myeloid leukemia: a clinical report of 86 cases
Association of 5-factor modified frailty index and controlling nutritional status score with overall survival in patients with unresectable hepatocellular carcinoma undergoing interventional therapy
Construction and validation of prediction model for cervical cancer recurrence based on systemic inflammation response index and clinicopathological parameters
Related Author
WANG Chengfang
ZHOU Yuqin
ZHANG Yanling
QI Xiaowei
ZHANG Yi
TONG Huyun
CHEN Xu
ZHANG Wenjie
Related Institution
Department of Breast and Thyroid Surgery, First Affiliated Hospital, Army Medical University (Third Military Medical University)
Department of Gastroenterology, Chongqing Hechuan District People’s Hospital
School of Medicine, Chongqing University
Chongqing Key Laboratory of Precision Prevention and Treatment for Digestive System Tumors, Department of Gastroenterology, Army Medical Center of PLA/Daping Hospital of Third Military Medical University
Department of Hematology, the First Hospital of Lanzhou University